| abstract |
The invention provides specific binding and suppress the human antibody of people TNF sample ligand 1 A (hTL1A) or the Fab of people's antibody.People anti-hTL1A antibody can be used for the treatment disease relevant to TL1A or illness, and such as inflammatory diseases or illness, such as, comprise the inflammatory bowel of ulcerative colitis and Crohn disease, rheumatoid arthritis etc.; Autoimmune disease or illness, such as multiple sclerosis, diabetes etc.; And atopic reaction, such as asthma and allergic pneumonia. |